dizziness; her legs and body felt heavy; body felt numb inside; thickening of tongue and throat; thickning of tongue and throat; body in hypermode; tingling in throat; tingling in tongue; muscle tightening up; flushing from her head to her feet; She has arthritis; muscle spasm; numbness; pain in arm; headaches; Joint pain from knuckles to knees; chills; Muscle aches \ pain from arm; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), LIMB DISCOMFORT (her legs and body felt heavy), HYPOAESTHESIA (body felt numb inside), SWOLLEN TONGUE (thickening of tongue and throat) and PHARYNGEAL SWELLING (thickning of tongue and throat) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 001B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical information was provided by the reporter.  Concomitant products included ZINC, VITAMIN D3 and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), LIMB DISCOMFORT (her legs and body felt heavy), HYPOAESTHESIA (body felt numb inside), SWOLLEN TONGUE (thickening of tongue and throat), PHARYNGEAL SWELLING (thickning of tongue and throat), PSYCHOMOTOR HYPERACTIVITY (body in hypermode), PHARYNGEAL PARAESTHESIA (tingling in throat), PARAESTHESIA ORAL (tingling in tongue), MUSCLE TIGHTNESS (muscle tightening up), FLUSHING (flushing from her head to her feet), ARTHRITIS (She has arthritis), MUSCLE SPASMS (muscle spasm), HYPOAESTHESIA (numbness), PAIN IN EXTREMITY (pain in arm), HEADACHE (headaches), ARTHRALGIA (Joint pain from knuckles to knees), CHILLS (chills) and FATIGUE (extreme fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form; Physical therapy for Muscle tightness; Physical therapy for Flushing; Physical therapy for Arthralgia and Physical therapy for Chills. At the time of the report, DIZZINESS (dizziness), LIMB DISCOMFORT (her legs and body felt heavy), HYPOAESTHESIA (body felt numb inside), SWOLLEN TONGUE (thickening of tongue and throat), PHARYNGEAL SWELLING (thickning of tongue and throat), PSYCHOMOTOR HYPERACTIVITY (body in hypermode), PHARYNGEAL PARAESTHESIA (tingling in throat), PARAESTHESIA ORAL (tingling in tongue), MUSCLE TIGHTNESS (muscle tightening up), FLUSHING (flushing from her head to her feet), ARTHRITIS (She has arthritis), MUSCLE SPASMS (muscle spasm), HYPOAESTHESIA (numbness), PAIN IN EXTREMITY (pain in arm), HEADACHE (headaches), ARTHRALGIA (Joint pain from knuckles to knees), CHILLS (chills) and FATIGUE (extreme fatigue) outcome was unknown.            Other treatment including physical therapy, acupuncture was reported. Concomitant medication also included flavonoids, and others. Action taken with mRNA-1273 in response to the events was not applicable.     Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Additional information include email address and events added. On 23-Jul-2021: Additional information include contact information updated.